Award for Science Outreach or Patient Advocacy Grant

Award for Science Outreach or Patient Advocacy Grant

Status: ACTIVE
Funder: Oligonucleotide Therapeutics Society
Amount: US $500
Last Updated: February 28, 2026

Summary

The Oligonucleotide Therapeutics Society (OTS) established the Awards for Science Outreach and Patient Advocacy to honor individuals who significantly contribute to science communication and patient advocacy. These awards recognize efforts in sharing scientific knowledge and supporting patients, aiming to foster community engagement. Recipients receive a $500 award, a certificate, complimentary registration to the OTS Annual Meeting, a featured profile on social media, and the opportunity to present a webinar, encouraging further outreach and education.

Overview

About the Oligonucleotide Therapeutics Society (OTS) The idea for the OTS was conceived in 2001 in a small secluded castle in Tuscany, Italy, by an international group of renowned oligonucleotide scientists. The idea of the founders was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities,very much like the impact that antibodies had on human therapeutics over the last decade. Incorporated in the State of Massachusetts in 2002 and granted 501(c)6 nonprofit status with the United States Internal Revenue Service in 2003, the Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics. The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in chemistry and delivery, to biology, immunology and clinical medicine. It is the intense scientific exchange between attendees during our annual meetings that sets the stage for groundbreaking new ideas. Our Mission The Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics. OTS Awards for Science Outreach and Patient Advocacy One of OTS’s core values is to provide trustworthy information to the public, to provide access to experts, and to amplify the voices of patients. In 2022, the society established two awards to recognize outstanding contributions by individuals who share their scientific knowledge with the public, or who promote patient advocacy. The OTS Awards for Science Outreach and Patient Advocacy aim to recognize the efforts of researchers and individuals who excel in these areas. OTS welcomes nominations for both of these awards annually. Recipients receive: $500 USD award & certificateComplimentary registration to the current year’s OTS Annual MeetingFeatured profile on OTS social mediaOption to present a webinar

Eligibility

You can learn more about this opportunity by visiting the funder's website. Any individual who is making a positive change in the community through science outreach or patient advocacy can be nominated, regardless of affiliation or career status

Ineligibility

Prior winners are not eligible